Penta ID Network Meeting (PIM) 2022
25 May, 2022
The Penta ID Network Meeting 2022 (PIM, 28-30 April 2022) gave our members – the Penta family – a great opportunity to meet face-to-face, after more than two years of distance due…
Read More
Youth engagement and participation in clinical trials
20 May, 2022
Involving patients in our clinical trials is of utmost importance to us. Penta is dedicated to ensuring that the young people in our trials are included at various stages of…
Read More
Penta at the Global Child Health Mini-Symposium in Oxford April 7th 2022
19 May, 2022
Penta was highly represented at the Mini-Symposium hosted by Green Templeton College – University of Oxford on the 7th of April 2022 entitled “Serving the children of the world: examining…
Read More
Penta investigates cases of acute hepatitis of unknown origin in children
18 May, 2022
On 12 May, a Rapid Communication on the reported increase of acute hepatitis of unknown origin in children was published in Eurosurveillance. The paper outlines the extent and geographical distribution…
Read More
RBDCOV initiates the first Phase III clinical trial of HIPRA’s Covid-19 vaccine in immunocompromised people
18 May, 2022
One of the objective of RBDCOV is to test whether the vaccine can reactivate or re-generate a protective immune response against the virus The RBDCOV project, in which Penta is…
Read More
Capacitating the future of research in paediatric HIV
16 May, 2022
[vc_row][vc_column][vc_column_text]By design, capacity building is a fundamental part of the UNIVERSAL project. The aim of the project’s capacity building activities are to improve the ability of African and European young…
Read More
The EPIICAL story
11 May, 2022
In 2016 the Early-treated Perinatally HIV-infected individuals: Improving Children’s Actual Life (EPIICAL) consortium began gathering scientists and clinicians specialising in paediatric HIV to work towards establishing new, scientific efforts on…
Read More
The D3 study has screened the first 2 children
27 Apr, 2022
Great day for the D3 study, today. The first 2 children have been screened for the study at the Prapokklao Hospital in Thailand. Thanks to the MRC CTU and the…
Read More
PentaTr@ining 2022: online course kicks off!
25 Apr, 2022
Our interactive course PentaTr@ining 2022: ‘HIV & other Congenital Infections’ kicks off today! The innovative online programme comprises 6 interactive and in-depth training modules, a wide variety of real-life clinical cases for…
Read More
Borrowing information across patient subgroups in clinical trials
23 Mar, 2022
An article by investigators within the ODYSSEY trial has been published as Open Access into BMC Medical Research Methodology. The investigators aimed to evaluate a treatment effect in a pre-defined subgroup…
Read MoreDolutegravir dosing for children with HIV weighing less than 20 kg
23 Mar, 2022
The results of an ODYSSEY pharmacokinetic sub-study investigating dolutegravir (DTG) based antiretroviral (ARV) treatments for children weighing 3 to less than 20kg have recently been published in The Lancet HIV as an…
Read MoreBirth outcomes following prenatal exposure to dolutegravir: the DOLOMITE-EPPICC study
18 Mar, 2022
Abstract Dolutegravir (DTG) is recommended and widely used during pregnancy for maternal viral suppression and preventing perinatal transmission of HIV. Our objective is to assess pregnancy and neonatal outcomes including…
Read More2-year outcome of early treated infants in Sub-Saharan Africa
18 Mar, 2022
Abstract The real-world evolution of very early treated children born with HIV in high-prevalence settings during first years of life is unclear. We assessed the probability of death, progression to…
Read More
What is PentaTr@ining
15 Mar, 2022
PentaTr@ining (formerly ‘Tr@inforPedHIV’) is a groundbreaking training platform for healthcare professionals caring for children, adolescents and pregnant women living with infectious diseases – with a particular focus on HIV and…
Read More
WHO Paediatric ARV dosing dashboard
14 Mar, 2022
The WHO have developed a Paediatric ARV dosing dashboard which aims to support health care workers, researchers and policy makers in decisions around ARV dosing for children. It includes a…
Read More
Penta stands with the Ukrainian people and those in Russia who are opposing war
02 Mar, 2022
On 24 February 2022, the Russian government deployed its military into its neighboring country, Ukraine. In these dark hours, we are tormented by the thought of our Ukrainian friends, the…
Read More
Gap-f launches strategy plan!
01 Mar, 2022
On March 1, 2022, the GAP-f network held a virtual event to launch its ambitious three-year strategy, spanning from 2022-2024. Through this event, the network solidified the WHO’s commitment to…
Read More
VERDI General Assembly Meeting
16 Feb, 2022
On 26-28 January the VERDI General Assembly Meeting took place – an exciting 3-day online event bringing together experts in infectious diseases from the EU and beyond. The aim was…
Read More